Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen, HandyLab Expand Probe Licensing Deal

NEW YORK (GenomeWeb News) – Nanogen today said that it has expanded a licensing agreement with HandyLab for the firm's probe technology and synthetic nucleic acid chemistries.

San Diego-based Nanogen said that HandyLab has received non-exclusive rights to market, sell, and distribute PCR kits that utilize its Minor Groove Binder Probe technology and related chemistries, dyes, and quenchers for in vitro diagnostic testing. HandyLab will use the technology in its Jaguar System.

HandyLab will pay Nanogen an upfront license fee. Other financial terms of the alliance were not disclosed.

The agreement expands an existing partnership between the firms that began last year when the US Centers for Disease Control and Prevention awarded a $10.4 million contract to Nanogen to develop a multi-analyte molecular diagnostic assay for influenza. That test is being developed for use with a HandyLab microfluidic, real-time PCR Raider instrument.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.